- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Observations following discontinuation of long-term denosumab therapy ; day:31 ; month:1 ; year:2017 ; pages:1-10
Osteoporosis international ; (31.1.2017), 1-10
- Keyword
-
Orthopädie
- Creator
-
McClung, M. R.
- Contributor
-
Wagman, R. B.
Miller, P. D.
Wang, A.
Lewiecki, E. M.
SpringerLink (Online service)
- DOI
-
10.1007/s00198-017-3919-1
- URN
-
urn:nbn:de:1111-201702258207
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McClung, M. R.
- Wagman, R. B.
- Miller, P. D.
- Wang, A.
- Lewiecki, E. M.
- SpringerLink (Online service)
Other Objects (12)
Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
Rebound activation of 5-HT neurons following SSRI discontinuation
Response to letter to the Editors—Safety of long-term denosumab therapy
Development of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine
Denosumab and muscle performance
Denosumab: A comprehensive review
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature
Monoclonal antibody desensitization in a patient with a generalized urticarial reaction following denosumab administration
Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
Rebound activation of 5-HT neurons following SSRI discontinuation
Response to letter to the Editors—Safety of long-term denosumab therapy
Development of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine
Denosumab and muscle performance
Denosumab: A comprehensive review
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature
Monoclonal antibody desensitization in a patient with a generalized urticarial reaction following denosumab administration
Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
Rebound activation of 5-HT neurons following SSRI discontinuation
Response to letter to the Editors—Safety of long-term denosumab therapy
Development of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine
Denosumab and muscle performance
Denosumab: A comprehensive review
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature